Institutional investors control 48.30% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2015, these large investors purchased a net $793.6 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NEW JERSEY DIVISION OF INVESTMEN... Bought 650.0 Thousand shares of Geron Corp